Healthcare provider engagement during this phase sets the stage for successful longer-term therapy
With India-specific pricing and the same cost for the first three doses, we are reinforcing our commitment to address the countrys growing obesity burden," said Vikrant Shrotriya, Managing Director of Novo Nordisk India
How GLP-1 Agonists Work Differently from GLP-1/Glucagon-like Peptide-1
Probably the game-changing study in the New England Journal, which I was corresponding author on, was STEP 1, which actually launched semaglutide to the world which for the first time caused a result in a 15% weight loss at the end of a year
However, there are a few differences between the two
GLP-1 receptor agonist medicines mimic this hormone which is why they can support both blood-sugar control in type 2 diabetes and medically supervised weight management